The venture was found in Asia in Hong Kong. The main office of represented VC is situated in the Hong Kong.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Virtus Inspire Ventures, startups are often financed by GV, Novartis, InCube Ventures. The meaningful sponsors for the fund in investment in the same round are Shire, SV Tech Ventures, Ping An Ventures. In the next rounds fund is usually obtained by Decheng Capital, B. Braun Medical.
Among the most popular portfolio startups of the fund, we may highlight Apexigen, Rani Therapeutics, Gordian Surgical. The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Life Science, Health Care.
The fund was created by Vic Lee. We also calculated 2 valuable employees in our database.
The important activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations.
Related Funds
Funds with similar focus
Fund Name | Location |
Algo Capital | Boston, Massachusetts, United States |
Barloworld Equipment | Gauteng, Johannesburg, South Africa |
Camros Capital | Boston, Massachusetts, United States |
Corporation Ventures | Buenaventura, Colombia, Valle del Cauca |
Gedoumi.com | - |
Koor Corporate Venture Capital | Israel, Tel Aviv, Tel Aviv District |
Quest Capital Management, Inc . | Dallas, Texas, United States |
Sammons Financial | Iowa, United States, West Des Moines |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Design Pharmaceuticals | $5M | 12 Apr 2022 | Cambridge, Massachusetts, United States | ||
Apexigen | $65M | 24 Mar 2020 | California, United States | ||
$20M | 19 Jul 2019 | Beijing | |||
Apexigen | $58M | 08 Aug 2018 | California, United States | ||
SmartZyme BioPharma, Ltd. | 14 Mar 2018 | New York, United States | |||
Gordian Surgical | $2M | 07 Dec 2016 | North District | ||
Gordian Surgical | $1M | 20 Oct 2015 | North District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Design Pharmaceuticals | $5M | 12 Apr 2022 | Cambridge, Massachusetts, United States | ||
Apexigen | $65M | 24 Mar 2020 | California, United States | ||
$20M | 19 Jul 2019 | Beijing | |||
Apexigen | $58M | 08 Aug 2018 | California, United States | ||
SmartZyme BioPharma, Ltd. | 14 Mar 2018 | New York, United States | |||
Gordian Surgical | $2M | 07 Dec 2016 | North District | ||
Gordian Surgical | $1M | 20 Oct 2015 | North District |